KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Non-Current Assets (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Non-Current Assets for 17 consecutive years, with $60.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets fell 3.46% to $60.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $149.5 billion, a 114.89% increase, with the full-year FY2025 number at $60.6 billion, down 3.46% from a year prior.
  • Non-Current Assets was $60.6 billion for Q4 2025 at Bristol Myers Squibb, up from -$35.6 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $76.1 billion in Q4 2021 to a low of -$35.6 billion in Q3 2025.
  • A 5-year average of $31.4 billion and a median of $61.6 billion in 2025 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: skyrocketed 297.74% in 2024, then crashed 154.32% in 2025.
  • Bristol Myers Squibb's Non-Current Assets stood at $76.1 billion in 2021, then dropped by 8.55% to $69.5 billion in 2022, then crashed by 145.68% to -$31.8 billion in 2023, then surged by 297.74% to $62.8 billion in 2024, then fell by 3.46% to $60.6 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Non-Current Assets are $60.6 billion (Q4 2025), -$35.6 billion (Q3 2025), and $61.6 billion (Q1 2025).